Christian Walker

Christian Walker is a seasoned senior-management executive with over two decades of experience in life sciences and regenerative medicine, spanning from start-ups to established publicly traded companies. His expertise includes securing funding through various avenues, talent management, and overseeing the successful development, regulatory approval, and market launch of products.

Christian has a diverse educational background, including a BA in Biology from the University of California, Santa Cruz, an MS in Biomedical Engineering from the University of Massachusetts Medical School, an MBA in Entrepreneurship from the University of Massachusetts at Amherst - Isenberg School of Management, an MEd in Science Education from the University of Massachusetts Boston, and an MA in Cell and Molecular Biology from The University of Texas at Austin.

Throughout his career, Christian has held key roles such as CEO & Founder at Peripheral Therapeutics, Business & Translational Development at Neuraptive Therapeutics, and Regenerative Medicine Commercialization at AxoGen, Inc. He has also been involved in various capacities at organizations like The Henry M. Jackson Foundation for the Advancement of Military Medicine, Johns Hopkins Medicine, and Harvard Medical School.

Christian has been instrumental in taking products from conception to market, navigating FDA regulations, and conducting human clinical trials. His skill set encompasses talent management, scientific expertise, and a proven track record in raising capital through avenues like angel investments, venture capital, and IPOs.

Christian's extensive background ranges from handling grant writing to overseeing the development of HIPAA compliant devices, illustrating his proficiency in both scientific and business realms. He has a demonstrated ability to lead teams, articulate strategic visions, and drive successful outcomes in the life sciences and regenerative medicine sectors.